We are live on ! Find out more
KRON

Kronos Bio

Delisted

KRON was delisted on the 20th of June, 2025.

63 hedge funds and large institutions have $39.3M invested in Kronos Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 13 increasing their positions, 21 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

2.92% less ownership

Funds ownership: 54.82%51.9% (-2.9%)

21% less funds holding

Funds holding: 8063 (-17)

28% less capital invested

Capital invested by funds: $54.3M → $39.3M (-$15M)

38% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 21

85% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 20

Holders
63
Holders Change
-17
Holders Change %
-21.25%
% of All Funds
1%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
3
Increased
13
Reduced
21
Closed
20
Calls
$35K
Puts
Net Calls
+$35K
Net Calls Change
+$5K

KRON Hedge Fund Activity: Q3 2023 in Review

63 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q3 2023, worth a combined $39.3M — down 28% from $54.3M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of KRON and 3 opened new positions — a net loss of 17 holders — while 21 trimmed existing stakes and 13 added.

The largest buyer was Acuta Capital Partners, adding an estimated $652K. The largest seller was Cerity Partners, exiting entirely with an estimated $730K sold.

  • 63 institutional investors held Kronos Bio (KRON) as of Q3 2023, down from 80 in Q2 2023.
  • Funds reported $39.3M of Kronos Bio stock for Q3 2023, down 28% quarter-over-quarter.
  • 3 funds opened new Kronos Bio positions in Q3 2023 and 20 closed out, a net change of -17 holders.
  • The largest Kronos Bio buyer in Q3 2023 was Acuta Capital Partners, an estimated $652K added.
  • The largest Kronos Bio seller in Q3 2023 was Cerity Partners, an estimated $730K sold.

Based on aggregated 13F filings for Q3 2023.